Articles by Disease (Non Hodgkin's Lymphoma)

Hepatitis C Viruss Immune Evasion Strategies

Journal: Current Immunology Reviews (Discontinued)
Volume: 1
Page: 223-235
Author(s): Michael W. Cruise, John R. Lukens and Young S. Hahn

Molecular Functions of BCL10 and MALT1 in Normal and Neoplastic Lymphocytes

Journal: Current Immunology Reviews (Discontinued)
Volume: 1
Page: 287-296
Author(s): Jurgen Ruland

HIV and Respiratory Disease: A Contemporary Perspective

Journal: Current Respiratory Medicine Reviews
Volume: 1
Page: 307-315
Author(s): Albert E. Holt IV, Wendy Turenne and Anthony D. Slonim

Genetic Idiotypic and Tumor Cell-Based Vaccine Strategies for Indolent Non Hodgkins Lymphoma

Journal: Current Gene Therapy
Volume: 5
Page: 511-521
Author(s): Pier A. Ruffini, Massimo Di Nicola, Carmelo Carlo-Stella, Salvatore Siena and Alessandro M. Gianni

Direct Evidence on the Immune-Mediated Spontaneous Regression of Human Cancer: An Incentive for Pharmaceutical Companies to Develop a Novel Anti-Cancer Vaccine

Journal: Current Pharmaceutical Design
Volume: 11
Page: 3531-3543
Author(s): F. Saleh, I. Klepacek, G. Ibrahim, H. Dashti, S. Asfar, A. Behbehani, H. Al-Sayer and A. Dashti

The Formulation of Lipid-Based Nanotechnologies for the Delivery of Fixed Dose Anticancer Drug Combinations

Journal: Current Drug Delivery
Volume: 2
Page: 341-351
Author(s): Euan C. Ramsay, Nancy D. Santos, Wieslawa H. Dragowska, Janessa J. Laskin and Marcel B. Bally

Ligand-Targeted Liposomes for Cancer Treatment

Journal: Current Drug Delivery
Volume: 2
Page: 369-381
Author(s): Puja Sapra, Pradeep Tyagi and Theresa M. Allen

Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects

Journal: Current Drug Targets - Cardiovascular & Hematological Disorders
Volume: 5
Page: 355-375
Author(s): Antonis S. Manolis, Stylianos Tzeis, Kostas Triantafyllou, John Michaelidis, Ioannis Pyrros, Nikolaos Sakellaris, Athanasios Kranidis and Helen Melita

New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy

Journal: Current Cancer Drug Targets
Volume: 5
Page: 393-419
Author(s): Christian Hafner, Albrecht Reichle and Thomas Vogt

Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy

Journal: Current Drug Targets
Volume: 6
Page: 631-646
Author(s): G. Sjoholt, N. Anensen, L. Wergeland, E. Mc Cormack, O. Bruserud and B. T. Gjertsen